Abstract:Based on a novel lead compound 4-methylpiperazine-1-carbodithioic acid 3-cyano-3,3-diphenylpropyl ester 1, the systematic structural modification was carried out. All the synthesized compounds were evaluated for their in-vitro anticancer activities on four to six different cell lines at three different concentrations. Most of the tested compounds could selectively inhibit the growth of HL-60 and Bel-7402 cell lines at a medium concentration. Four compounds (3f, 3g, 3n, and 5) were selected for the IC(50) test, and the results revealed that three compounds (3g, 3n, and 5) showed almost the same or a slightly weaker activity than compound 1 against HL-60, and three compounds (3f, 3g, and 3n) showed > 2-fold higher potency than compound 1 against Bel-7402. The in-vivo efficacy of 3n center dot HCl was evaluated with transplanted hepatocyte carcinoma 22 as an in-vivo test model. It was found that 3n center dot HCl could inhibit significantly the growth of tumor, and that this effect was dose-dependent. Meanwhile, the compound 3n center dot HCl showed low toxicity compared with compound 1 center dot HCl as evidenced by the little body-weight loss. These results confirmed that compound 3n center dot HCl is more potent than the lead compound 1 center dot HCl. Preliminary structure-activity relationships indicated that: a) Both nitrile group and the cyclic amine containing at least two nitrogens were indispensable moieties to keep the activity; b) substitution of the piperazine ring is unfavorable for the improvement of activity; c) the suitable linker joining the piperazinyl dithiocarboxyl and diphenylacetonitril group should be ethylene; d) a non-coplanar arrangement of the two benzene rings appears to be essential for activity.

Recombination of Diterpenoid Structure Units: Synthesis of Antitumor Amides Bearing Functionalized Bicyclo[3.2.1]octane Ring

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Structure-activity Relationships of Novel Dithiocarbamates Containing Α,β-Unsaturated Ketone Fragment As Potent Anticancer Agents

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis and Biological Evaluation of Novel Steroidal Pyrazole Amides As Highly Potent Anticancer Agents.

Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.

Synthesis and Structure-Activity Relationships of a Novel Class of Dithiocarbamic Acid Esters As Anticancer Agent.

Discovery and Optimization of Novel Dual Dithiocarbamates As Potent Anticancer Agents.

New Cytotoxic α-Aminoacylamide and bis-1,5-Disubstituted Tetrazole Adducts From Amino-Diterpene Molecules by Ugi Reaction

Synthesis, Biological Evaluation, and Molecular Docking Studies of Diacylhydrazine Derivatives Possessing 1,4-Benzodioxan Moiety As Potential Anticancer Agents

Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid

Design, Synthesis, Structure-Activity Relationships and Mechanism of Action of New Quinoline Derivatives As Potential Antitumor Agents

Synthesis of Caffeic Acid Amides Bearing 2,3,4,5-Tetra-hydrobenzo[b][1,4]dioxocine Moieties and Their Biological Evaluation As Antitumor Agents

Synthesis and Antitumor Activity of Novel N-substituted Carbazole Imidazolium Salt Derivatives

Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Synthesis and Biological Activity of 28-Amide Derivatives of 23-Hydroxy Betulinic Acid As Antitumor Agent Candidates.

Total Synthesis and Cytotoxicity of Bisebromoamide and Its Analogues

Synthesis And Anti-Tumor Study Of 3-Aryl-4-Oxo-Thiazolidin-2-Carboxylic Acid Amides

Synthesis and Anti-tumor Activities of Novel 18Β-Glycyrrhetinic Acid Derivatives Attaching Dithiocarbamate Units